Research & Development In Brief
This article was originally published in The Tan Sheet
Executive Summary
Report addresses PPIs, antiplatelet therapy
You may also be interested in...
PPI-Clopidogrel Shows Benefit, But Omeprazole Concern Remains - Study
An analysis shows a benefit from using proton pump inhibitors with clopidogrel compared with using the antiplatelet drug alone, but reinforces concerns that the PPI omeprazole diminishes the efficacy of the blood thinner
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off
FDA plans to revise monograph language for over-the-counter pediatric cough/cold products, but the agency is seeking input on some basic data questions first, indicating many steps will be taken before a rule can be finalized
ImmunoGen’s Elahere Data In Avastin-Naïve Ovarian Cancer Prompt Discussion About Earlier Use
The presenter on the MIRASOL study called the data “practice changing,” while the discussant cited Sutro’s STRO-002 as a potential option for patients with low folate receptor alpha expression.